Global Patent Index - EP 0941088 B1

EP 0941088 B1 20030305 - USE OF CONJUGATED LINOLEIC ACID TO ENHANCE NATURAL KILLER LYMPHOCYTE FUNCTION

Title (en)

USE OF CONJUGATED LINOLEIC ACID TO ENHANCE NATURAL KILLER LYMPHOCYTE FUNCTION

Title (de)

VERWENDUNG VON KONJUGIERTES LINOLENSÄURE ZUR STEIGERUNG DER AKTIVITÄT VON NATURAL KILLER-LYMPHOZYTEN

Title (fr)

UTILISATION DE L'ACIDE LINOLEIQUE CONJUGUE POUR AMELIORER LA FONCTION DES LYMPHOCYTES TUEURS NATURELS

Publication

EP 0941088 B1 20030305 (EN)

Application

EP 97945605 A 19971104

Priority

  • US 9720098 W 19971104
  • US 3039496 P 19961105

Abstract (en)

[origin: US5914346A] A method of enhancing the activity of natural killer lymphocytes and a method for increasing the basal level of natural killer activity in an animal include the step of administering orally or parenterally to said animal a safe amount of CLA, said amount being effective to enhance the activity of killer lymphocytes or to enhance the basal activity of killer lymphocytes in the animal.

IPC 1-7

A61K 31/23; A61P 35/00; A61P 37/00

IPC 8 full level

A23K 1/16 (2006.01); A61K 31/201 (2006.01); A61K 31/231 (2006.01); A61P 43/00 (2006.01)

CPC (source: EP US)

A61K 31/231 (2013.01 - EP US); A61P 35/00 (2018.01 - EP); A61P 37/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP)

Citation (examination)

Ip, C. et al.: Cancer Research, 51, 1991, pp. 6118-6124

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9819675 A1 19980514; AT E233557 T1 20030315; AU 5104198 A 19980529; CA 2267109 A1 19980514; CA 2267109 C 20060822; DE 69719539 D1 20030410; EP 0941088 A1 19990915; EP 0941088 B1 20030305; JP 2001503430 A 20010313; US 5914346 A 19990622

DOCDB simple family (application)

US 9720098 W 19971104; AT 97945605 T 19971104; AU 5104198 A 19971104; CA 2267109 A 19971104; DE 69719539 T 19971104; EP 97945605 A 19971104; JP 52171998 A 19971104; US 96374097 A 19971104